Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients.

[1]  J. Park,et al.  Effect of recombinant human erythropoietin on muscle energy metabolism in patients with end-stage renal disease: a 31P-nuclear magnetic resonance spectroscopic study. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  B. Brenner,et al.  Anemia ameliorates progressive renal injury in experimental DOCA-salt hypertension. , 1991, Journal of the American Society of Nephrology : JASN.

[3]  J. Spivak,et al.  Treatment of the anemia of chronic renal failure with subcutaneous recombinant human erythropoietin. , 1990, The American journal of medicine.

[4]  A. Levey,et al.  Measurement of renal function in chronic renal disease. , 1990, Kidney international.

[5]  R. Asinger,et al.  Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients. , 1990, American journal of nephrology.

[6]  R. Degowin,et al.  Effect of recombinant human erythropoietin on renal function in humans. , 1990, Kidney international.

[7]  R. Abels,et al.  The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function: a double-blind, placebo-controlled trial. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  R. Degowin,et al.  The safety and the efficacy of maintenance therapy of recombinant human erythropoietin in patients with renal insufficiency. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  J. Adamson,et al.  Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. , 1989, The New England journal of medicine.

[10]  B. Kahan The impact of cyclosporine on the practice of renal transplantation. , 1989, Transplantation proceedings.

[11]  R. Degowin,et al.  Recombinant human erythropoietin treatment in pre-dialysis patients. A double-blind placebo-controlled trial. , 1989, Annals of internal medicine.

[12]  D. Peterson,et al.  Hematologic and physiologic studies during correction of anemia with recombinant human erythropoietin in predialysis patients , 1989 .

[13]  R. Verberckmoes,et al.  Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  T. Pincus,et al.  Treatment of the Anemia of Predialysis Patients with Recombinant Human Erythropoietin: A Randomized, Placebo‐Controlled Trial , 1988, The American journal of the medical sciences.

[15]  B. Brenner,et al.  Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[16]  N. Gretz,et al.  Efficacy and side effects of erythropoietin used in the treatment of anemia of uremic rats. , 1988, Contributions to nephrology.

[17]  D. Harris,et al.  Phosphate depletion arrests progression of chronic renal failure independent of protein intake. , 1986, Kidney international.

[18]  B. Brenner Nephron adaptation to renal injury or ablation. , 1985, The American journal of physiology.

[19]  W. Mitch,et al.  A method for estimating nitrogen intake of patients with chronic renal failure. , 1985, Kidney international.

[20]  W. Sluiter,et al.  PROSPECTIVE RANDOMISED TRIAL OF EARLY DIETARY PROTEIN RESTRICTION IN CHRONIC RENAL FAILURE , 1984, The Lancet.

[21]  W. Mitch,et al.  A SIMPLE METHOD OF ESTIMATING PROGRESSION OF CHRONIC RENAL FAILURE , 1976, The Lancet.

[22]  B. Brenner,et al.  Dynamics of Glomerular Ultrafiltration in the Rat: VIII. EFFECTS OF HEMATOCRIT , 1975, Circulation research.

[23]  A. Hull,et al.  Measurement of glomerular filtration rate utilizing a single subcutaneous injection of 125I-iothalamate. , 1973, Kidney international.

[24]  M. Black Letter: Cryostat sections in immunological studies of cancer. , 1973, Lancet.

[25]  B. Brenner,et al.  The dynamics of glomerular ultrafiltration in the rat. , 1971, The Journal of clinical investigation.

[26]  D. M. Allen,et al.  Analysis of growth and dose response curves. , 1969, Biometrics.